References
- Atkinson M, Nordin B EC, Sherlock S. Malabsorption and bone disease in prolonged obstructive jaundice. Q J Med 1955; 99: 229–312
- Dibble J B, Sheridan P, Hampshire R. Osteomalacia vitamin D deficiency and cholestasis in chronic liver disease. Q J Med 1982; 51: 89–103
- Summerskill W HJ, Kelly P J. Osteoporosis with fractures in anicteric cirrhosis: observations supplemented by microradiographic evaluation of bone. Proc Mayo Clin 1963; 38: 162–174
- Paterson C R, Losowske M S. The bones in chronic liver disease. Scand J Gastroenterol 1967; 2: 293–300
- Calcium and chronic liver disease. Lancet 1987; 2: 1065–1066
- Bengoa J M, Sitrin M D, Meredith S. Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease. Hepatology 1984; 4: 261–265
- Fonseca V, Epstein O, Gill D S. Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis. J Clin Endocrinol Metab 1987; 64: 873–877
- Arlot M E, Bonjean M, Chavassieux P M, Meunier P J. Bone histology in adults with aseptic necrosis. J Bone Joint Surg 1983; 65-A: 1319–1327
- Vernejoul M C, Bielakoff J, Herue M. Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle aged men. Clin Orthop 1983; 179: 107–115
- Cameron J R, Sorensen J. Measurement of bone mineral in vivo: an improved method. Science 1963; 142: 273–279
- Mazess R B, Wahner H M. Nuclear medicine and densitometry. Osteoporosis: etiology, diagnosis and management, B L. Riggs, LJ Melton, III. Raven Press, New York 1988; 254–259
- Pietschmann P, Wotoszczuk W, Panzer S, Kyrle P, Smolen J. Decreased serum osteocalcin levels in phenoprocoumon-treated patients. J Clin Endocrinol Metab 1988; 66: 1071–1074
- Bikle D D, Genant H K, Cann C, Recker R, Hal-Loran B, Strewler G. Bone disease in alcohol abuse. Ann Intern Med 1985; 103: 42–48
- Hepner G W, Roginsky M, Fai Moo M. Abnormal vitamin metabolism in patients with cirrhosis. Dig Dis 1976; 21: 527–532
- Long R G, Wills M R, Skinner R K. Serum 25-hydroxy-vitamin D in alcoholics with varying degrees of liver affection. Acta Med Scand 1977; 202: 221–224
- Long R G, Meinhard E, Skinner R K, Varghese Z, Wills M R, Sherlock S. Clinical, biochemical and histological studies of osteomalacia, osteoporosis and parathyroid function in chronic liver disease. Gut 1978; 19: 85–90
- Price P A, Parthemore J G, Deftos L G, Nishimoto S K. New biochemical marker for bone metabolism. J Clin Invest 1980; 66: 878–883
- Gallop P M, Lian J B, Hauschka P V. Caboxyrelated calcium binding proteins and vitamin K. N Engl J Med 1980; 302: 1460
- Brown J P, Malaval L, Chapuy M C, Delmas P D, Edouard C, Meunier P J. Serum bone GLA-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984; 1: 1091–1093
- Voneda M, Takatsuki K, Yamauchi K. Influence of thyroid function on serum bone Gla protein. Endocrinol Jpn 1988; 35: 121–129
- Lukert B P, Higgins J C, Stoskopf M M. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 1985; 62: 1056
- Pietschmann P, Resch H, Muller C, Woloszczuk W, Willvonseder R. Decreased serum osteocalcin levels in patients with liver cirrhosis. Bone Mineral 1989, in press
- Reichling J J, Marshall M K. Clinical use of serum enzymes in liver disease. Dig Dis Sci 1988; 33: 1601–1614
- Rico H, Cabranes A, Cabello J, Gomez-Castresana F, Hernandez E R. Low serum osteocalcin in acute alcohol intoxication: a direct toxic effect of alcohol on osteoblasts. Bone Mineral 1987; 2: 221–225